• Cefodizime: Applied Workflows for Third-Generation Cephalosp

  2026-04-30

  Cefodizime, a third-generation cephalosporin antibiotic, delivers robust broad-spectrum antibacterial and immunomodulatory activity for advanced microbiology workflows. This article details optimized experimental protocols, troubleshooting, and comparative advantages, empowering researchers to leverage APExBIO’s high-quality Cefodizime for reliable infectious disease modeling and resistance studies.

• Applied Use-Cases of Probenecid in MDR and Neuroprotection R

  2026-04-30

  Probenecid (4-(dipropylsulfamoyl)benzoic acid) from APExBIO empowers multidrug resistance reversal and neuroprotection with unrivaled versatility. Integrating precise transporter inhibition, it unlocks new experimental strategies across oncology and neuroscience, surpassing conventional reagents.

• XPO1 Inhibition by Eltanexor Reduces Colorectal Tumorigenesi

  2026-04-29

  This study demonstrates that Eltanexor (KPT-8602), a second-generation XPO1 inhibitor, effectively reduces colorectal cancer tumor burden by modulating the Wnt/β-catenin signaling pathway. The findings establish nuclear export inhibition as a promising chemopreventive approach in genetically predisposed colorectal cancer models.

• A23187, Free Acid: Calcium Ionophore for Intracellular Ca2+

  2026-04-29

  A23187, free acid is a well-characterized calcium ionophore used to elevate intracellular Ca2+ and dissect calcium-dependent signaling in vitro. It enables precise, reproducible modulation of cell signaling pathways including phosphoinositide hydrolysis and apoptosis induction via mitochondrial permeability. APExBIO’s A23187, free acid (B6646) sets a benchmark for experimental reliability in cell signaling and apoptosis studies.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody: Technic

  2026-04-28

  HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive, specific fluorescent detection of rabbit primary antibodies, addressing the need for robust signal amplification in immunoassays. It is best employed in immunofluorescence, immunohistochemistry, and flow cytometry workflows where high specificity and minimal cross-reactivity are required. Not recommended for non-rabbit primary antibodies or protocols incompatible with sodium azide.

• Firefly Luciferase mRNA: 5-moUTP Reporter Assays Optimized

  2026-04-28

  Leverage 5-moUTP-modified Firefly Luciferase mRNA for high-sensitivity bioluminescent reporting with reduced innate immune activation and robust translation efficiency. This guide details practical workflows, troubleshooting strategies, and advanced assay design informed by cutting-edge RNA delivery research.

• EZ Cap™ Firefly Luciferase mRNA: Enhanced Bioluminescent Ass

  2026-04-27

  EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure sets a new benchmark for mRNA delivery, translation efficiency, and in vivo imaging. Explore workflow optimizations, data-driven protocol parameters, and troubleshooting strategies that maximize reporter assay sensitivity with this robust, next-generation mRNA reagent.

• Applied Workflows with EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

  2026-04-27

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) empowers researchers to simultaneously track mRNA delivery and translation efficiency with dual fluorescence, Cap 1 capping, and immune-evasive nucleotide modifications. Learn how to optimize gene regulation assays, troubleshoot delivery bottlenecks, and leverage machine learning–driven nanoparticle innovations for reproducible, quantitative results.

• SEMA3E Drives Beige Adipocyte Thermogenesis via β-Catenin Pa

  2026-04-26

  This study uncovers the regulatory role of SEMA3E in promoting beige adipocyte differentiation and thermogenesis by modulating β-catenin signaling in mice. The findings provide mechanistic insight into adipose tissue plasticity and metabolic regulation, offering new perspectives for inflammation and lipid metabolism research.

• Firefly Luciferase mRNA: Optimizing 5-moUTP-Based Reporter W

  2026-04-25

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) empowers highly sensitive, reproducible bioluminescent reporter assays and mRNA delivery validation. Its advanced 5-moUTP and Cap 1 modifications yield robust expression, innate immune suppression, and workflow flexibility—key for translation efficiency studies and in vivo imaging.

• Neutrophil NETs Drive Brain Injury via cGAS-STING Activation

  2026-04-24

  This study reveals that neutrophil extracellular traps (NETs) exacerbate surgical brain injury (SBI) by activating the cGAS-STING pathway, leading to heightened neuroinflammation and neuronal damage. Inhibiting NETs or cGAS-STING signaling mitigated injury, highlighting new therapeutic directions for SBI and offering mechanistic insight for translational research.

• TMRE Mitochondrial Membrane Potential Assay Kit: Mechanisms,

  2026-04-24

  Explore the scientific foundations and advanced applications of the TMRE mitochondrial membrane potential assay kit. This article uniquely integrates mechanistic insights from NECSO research, providing a deeper understanding for mitochondrial function analysis and apoptosis detection.

• TCAIM Modulates Mitochondrial Metabolism via OGDH Regulation

  2026-04-23

  Wang et al. (2025) identify the mitochondrial DNAJC co-chaperone TCAIM as a specific regulator of the α-ketoglutarate dehydrogenase (OGDH) protein, revealing a novel post-translational mechanism for metabolic control. This work has significant implications for understanding mitochondrial proteostasis and its effects on cellular energy production.

• Optimizing Neuroprotection Assays with IEM 1460 (SKU B6811)

  2026-04-23

  Discover how IEM 1460 (SKU B6811) addresses key lab challenges in AMPA receptor inhibition, neuroprotection, and synaptic transmission research. This guide provides scenario-driven, evidence-backed strategies for reliable data and assay reproducibility, positioning IEM 1460 as a trusted solution for neuroscience workflows.

• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-04-22

  This study benchmarks biomimetic open tubular capillary electrochromatography and immobilised artificial membrane chromatography, both coupled with mass spectrometry, for predicting the lung permeability of pharmaceuticals. The findings provide a robust analytical platform for high-throughput screening in respiratory drug development, informing the selection and optimization of anti-inflammatory corticosteroids such as Budesonide.

15607 records 1/1041 page Next 12345 下5页 Last page